Decade in review-hepatocellular carcinoma: HCC-subtypes, stratification and sorafenib.

Gregory J Gores

Journal: Nature reviews. Gastroenterology & hepatology 2016;11(11):645-7

PMID: 25245016

Free Full Text on PubMed Central View on PubMed

Abstract

The past 10 years have represented a whirlwind of activity with regard to information on the risk factors, aetiopathogenesis, diagnosis and treatment of hepatocellular carcinoma. I will describe what I consider to be the major advances from both a tumour biology perspective and a clinical perspective over the past 10 years.

Address: Division of Gastroenterology and Hepatology, Mayo College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

DOI: 10.1038/nrgastro.2014.157